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Claudin proteins are involved in the paracellular tightening of epithelia and endothelia. Their internalization,
which can be modulated by extracellular stimuli, for example, proinflammatory cytokines, is a prerequisite for the
regulation of the paracellular barrier to allow, for instance, cell migration or drug delivery. The internalization of
peptide sequences of claudins is completely unknown. Here, we studied the internalization of two peptides, TAMRA-
claudin-1 and TAMRA-claudin-5, derivatives of the extracellular loop of claudin-1 and -5, respectively, in either
epithelial or endothelial cells. The cellular uptake of the claudin-1 peptide follows the clathrin-mediated endocytosis
as indicated by inhibitors and respective tracers for colocalization. In addition, macropinocytosis and caveolae-
mediated endocytosis of the peptide was observed. In contrast, the claudin-5 peptide is mainly internalized via the
caveolae-mediated endocytosis evidenced by the colocalization with respective tracers and vesicle markers, whereas
the nonselective macropinocytosis seems to be involved in a less effective manner. In conclusion, the assumption is
supported that claudin peptides can be internalized by specific and nonspecific pathways.
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Introduction
Transmembrane tight junction (TJ) proteins seal the
paracellular cleft between epithelial and endothelial
cells.1–3 Moreover, TJ proteins regulate the paracel-
lular flux of fluids and solutes.1–3 However, little
is known about their intracellular function. Mem-
bers of these proteins are claudin proteins, occludin-
like proteins, and junctional adhesion molecules
(JAM). Consequently, proteins are located at cell–
cell contact membranes of opposing cells and form
a paracellular barrier. In contrast to the distinct
organization, there is a continuous flux of the pro-
teins by endocytosis followed by either recycling and
incorporationback to themembraneordegradation
and de novo synthesis.4 Endocytosis of the TJ pro-
teins can influence the paracellular barrier integrity
either due to one subtype, which is internalized,
∗These authors contributed equally.
or due to different subtypes, such as claudins and
occludin.4,5
The intracellular uptake of TJ proteins can
take place by three different endocytosis pathways,
caveolae-mediated, clathrin-mediated, or more un-
specifically, by macropinocytosis.6–8 The endocy-
tosis pathways differ between TJ proteins and can
be influenced by an extracellular stimulus, for
example proinflammatory cytokines.9 The tumor
necrosis factor- or interferon- induce internal-
ization of claudin-1, zonula occludens protein 1
(ZO-1) or JAM-A by clathrin-mediated endocyto-
sis and by macropinocytosis.10,11 By using a non-
physiological stimulus, like Ca2+ depletion, the
clathrin-mediated endocytosis of several TJ pro-
teins, for instance occludin and JAM-1, is initi-
ated.12 In contrast, caveolae-mediated endocytosis
and macropinocytosis have been observed for oc-
cludin and claudin-5 by the Escherichia coli toxin
cytotoxic necrotizing factor-1 or the chemokine lig-
and 2.4,13 However, nothing is known about the
doi: 10.1111/j.1749-6632.2012.06567.x
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internalization pathway of peptides designed from
claudin segments.
The 27 members of the claudin family are the
major component of TJ strands.14 Their expres-
sion pattern varies between different tissues and
these proteins are regulating the tissue-, charge-,
and size-selectivity.15,16 In the blood–brain bar-
rier, claudin-5 is the significant claudin subtype,17
whereas claudin-1 is essential for the tightness
of the epidermal barrier.18 Claudins contain four
transmembrane helices, an intracellular N- and C-
terminus as well as one intracellular loop and two
extracellular loops (ECL). The first ECL is with
∼50 amino acids much longer than the second one
with ∼10–20 amino acids. They can interact with
each other between the cell membranes of oppos-
ing cells (trans-interaction).19 Claudins are able to
interact in a homophilic (same claudin subtype) or
heterophilic (different claudin subtypes) manner.
However, the complete mechanism of interaction is
still unclear but both ECL seem to be involved.19–21
In this study, we investigated two fluorescently
labeled peptides derived from the ECL of claudin-1,
the 5,6-carboxytetramethylrhodamine (TAMRA)-
claudin-1 peptide, and derived from the ECL of
claudin-5, the TAMRA-claudin-5 peptide, with re-
spect to their internalization behavior. As claudin-1
is a key claudin for the epithelium and claudin-
5 for the endothelium epithelial and endothelial
cell lines were used. Both peptides are internal-
ized within few minutes and appear vesicle-like
distributed. The claudin-1–derived peptide enters
the cell via the clathrin-mediated endocytosis and
macropinocytosis as well as to lower amounts by
the caveolae-mediated endocytosis. In contrast, a
caveolae-mediated endocytosis but no clathrin-
mediated endocytosis, and low macropinocyto-
sis could be observed for the uptake of the
claudin-5-derived peptide. Furthermore, our re-
sults predominantly agree with data regarding the




Peptides were generated automatically (ACTIVO-
P11,Activotec.com,Cambridge,UK)by solid-phase
peptide synthesis using Fmoc/tBu chemistry. Syn-
thesis followed in a batch-wise mode at a distinct
temperature with coupling times of 10 min at
70 ◦C and the Fmoc-removal for seven minutes
at 70 ◦C on Peg-resins (SRAM, 0.2 mmol/g,
Rapp-Polymere [Sigma-Aldrich, Germany]).
TAMRA was introduced N-terminally after Fmoc-
removal to visualize the cellular pathway. Firstly,
TAMRA (5 equiv. per Peg-resin, 0.1 mmol) was
activated by 2-(6-chloro-1H-benzotriazole-1-yl)-
1,1,3,3-tetramethylaminium hexafluoro-phosphate
(0.1 mmol) and N ,N-diisopropylethylamine (0.2
mmol) and then coupled for 40 min in dimethyl-
sulfoxide with the respective resin. The cleavage
from the resin occurred with trifluoroacetic acid
(TFA)/H2O (9/1) for three hours at room temper-
ature. Then, peptides were precipitated with cold
diethyl ether and purified by preparative reversed
phase high-performance liquid chromatography
(C-18 column) (Dionex, Sunnyvale, CA) with
acetonitrile gradients in aqueous 0.1% TFA. Puri-
fied peptides were quantified and characterized by
liquid chromatography (ACQUITY UPLC system,
C18 column) electrospray time-of-flight mass
spectrometry (LCT Premier, Waters, Germany),
which showed a purity >95% (220 nm) and
gave the expected masses. For in vitro experi-
ments, TAMRA-labeled peptides were dissolved
in dimethyl sulfoxide (final concentration of
0.1%), and afterward added to the corresponding
medium containing pluronic R© F-127 (0.012%)
(Sigma-Aldrich, Germany).
Cell culture
Human embryonic kidney (HEK-293) cells22 sta-
bly transfected with claudin-1-yellow fluorescence
protein (YFP) and immortalized mouse brain en-
dothelial cells (bEnd.3)23 were grown at 37 ◦C and
10% CO2. The transfection was thought to visu-
alize colocalization between the claudin and the
peptide tested. HEK-293 claudin-1-YFP cells were
cultured in Dulbecco’s modified Eagle’s medium
(DMEM) containing 10% fetal calf serum, 100
units/mLpenicillin, 100g/mL streptomycin, and 4
mM l-analyl-l-glutamine. bEnd.3 cells and bEnd.3
caveolin-1-green fluorescent protein (GFP) cells
were cultured in DMEM containing 10% fetal calf
serum, 1× nonessential amino acids, and 2 mM
l-glutamine.
Inhibitor study
HEK-293 claudin-1-YFP cells were transferred
into 35 mm tissue culture dishes containing
poly-l-lysine-coated cover-slips and grown to
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subconfluence. Cells were pretreated with the re-
spective inhibitor: chlorpromazine,24 as inhibitor of
the clathrin-mediated endocytosis with 15 M for
30 min, wortmannin25 with 250 nM for 60 min or
LY294002 with 100M for 60min asmacropinocy-
tosis inhibitors, and filipin26 as inhibitor of the
caveolae-mediated endocytosis with 1 g/mL for
30 minutes. Afterward, cells were treated with the
TAMRA-claudin-1 peptide (40M) and the respec-
tive inhibitor for 35 minutes. Nuclei were stained
with 5 MHoechst 33342 (Life Technologies, Ger-
many). Then, cells were washed three times with
Hank’s buffered salt solution and analyzed by quan-
tification of the intracellular amount of peptidewith
the laser scanning microscope 510 Meta confocal
microscope (Zeiss, Germany).
Tracer study
Colocalization studies of TAMRA-claudin-1: HEK-
293-claudin-1-YFP cells were seeded as described
above. The clathrin internalization tracer Alexa680-
transferrin (25 g/mL) (Invitrogen, Carlsbad, CA)
and 40Mpeptidewere dissolved intomediumand
added to the apical side of HEK-293 claudin-1-YFP
cells. After 25 min at 37 ◦C, samples were analyzed
by confocal microscopy. Colocalization studies of
TAMRA-claudin-5: The macropinocytosis marker,
lysine-fixableAlexaFluor 488-dextran12 (1mg/mL),
the caveolae internalization marker, bodipy-FL4
(5 M), and the clathrin internalization marker,
FITC-transferrin27 (5 g/mL) (Invitrogen), were
dissolved in ice-cold medium (DMEM w/o phe-
nol red) and added to the apical side of bEnd.3
cell monolayers together with the TAMRA-claudin-
5 peptide (1–200 M). Monolayers were first kept
at 4 ◦C for 30 min to allow tracer accumulation on
the cell surface and then incubated for 0–30 min at
37 ◦C. All samples were viewed on a confocal laser
scanning microscope.
Immunofluorescence
The following antibodies were used: anti-Rab34
(Abcam, Boston, MA), -caveolin-1, and --adaptin
antibodies (BDBiosciences, Franklin Lakes,NJ) and
secondary antibodies antimouse-FITC and -rabbit-
FITC(Vector laboratories,Burlingame,CA).28 Sam-
ples were fixed in 4% paraformaldehyde and then
preincubated in the blocking solution containing
5% normal goat serum, 5% bovine serum albu-
mine, and 0.05% Tween 20 in phosphate-buffered
saline. Samples were then incubated with primary
antibodies overnight at 4 ◦C. Reactions were visual-
ized by fluorescence-conjugated antimouse and/or
antirabbit antibodies. All samples were viewed on a
confocal laser scanning microscope.
Evaluation of the endocytosis rate
To quantify the endocytosis rate of the peptide
with or without inhibitors, cells from four indepen-
dent experimentswere analyzed. For visualizationof
TAMRA-labeled peptides, excitationwas performed
at 543nm.All wavelengths greater than 560nmwere
collected as emission signal. For each treatment at
least 15pictureswithanaveragenumberof 24.1±0.4
cells were taken and the fluorescence intensity of
the internalized TAMRA-labeled peptide was deter-
mined by Zeiss LSM Image Browser Software (Zeiss,
Germany). For quantitation of the endocytosis, the
emission signals of TAMRA were used. The anal-
ysis of each picture provided by the LSM software
resulted in a histogram of the emission intensities
(0–255 relative fluorescence units, rfu), in which the
background (<150 rfu) and saturated signals (>254
rfu) were excluded. All signal events of a histogram
were added up to the number of signal events of a
picture. To allow comparison between different pic-
tures the events were normalized to the number of
the cells analyzed.
Evaluation of colocalization
To quantify the colocalization of claudin-5 peptide
and tracers or vesiclemarkers, each z-optical section
was analyzed using the colocalization finder plug-in
of ImageJ (National Institutes of Health, Bethesda,
MD). Cells from three independent experiments
and three areas per experiment were analyzed.
The background contribution to colocalization was
corrected using the formula: corrected colocal-
ization = measured colocalization – background
colocalization/1 – background colocalization/100.
The colocalization probability was estimated by
Pearson’s correlation coefficient (Rr). The Pear-
son coefficient ranges between –1 (perfect negative
correlation between two images) to +1 (perfect pos-
itive correlation between two images). A coefficient
of 0 means no correlation between two images.
Statistical analysis
Results are shown asmean± SEMaswell asmean±
SDobtainedby theMann–Whitney test (two-tailed)
and Bonferroni test (two-way ANOVA). Differences
were considered as significant if P < 0.05.
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Figure 1. The internalization of the claudin-1 peptide follows the clathrin-mediated and caveolae-mediated endocytosis as well
as macropinocytosis. (A) Epithelial human embryonic kidney (HEK)-293 claudin-1 yellow fluorescent protein (YFP) cells were
treatedwith the 5,6-carboxytetramethylrhodamine (TAMRA)-labeled claudin-1 peptide (40μM) for 35minutes. The picture shows
a clear intracellular distribution of the claudin-1 peptide (red) (arrows). (B–F) HEK-293 claudin-1-YFP cells were pretreated with
the corresponding endocytosis inhibitor or inhibitor cocktail. Then, cells were incubated with the claudin-1 peptide (40 μM)
and the inhibitor or inhibitor cocktail for 35 minutes. Arrows are indicating intracellular localization of the claudin-1 peptide.
(B) Filipin, an inhibitor of the caveolae-mediated endocytosis shows a reduction of the cellular uptake of the claudin-1 peptide.
(C) Chlorpromazine, an inhibitor of clathrin-mediated endocytosis leads to a higher decrease of intracellular claudin-1 peptide.
(D) An inhibition of internalized claudin-1 peptide could be obtained for wortmannin, an inhibitor of macropinocytosis. (E)
LY294002, another inhibitor of macropinocytosis, decreases the uptake of the claudin-1 peptide in a lesser amount as compared
to wortmannin. (F) The cocktail of the inhibitors chlorpromazine and wortmannin leads to the highest reduction in the cellular
uptake of the claudin-1 peptide. (G) Epithelial HEK-293 claudin-1-YFP cells were cotreated with the claudin-1 peptide (red) and
Alexa680-tranferrin (green) to determine colocalization. There is a clear colocalization (yellow, arrows) with Alexa680-transferrin,
a tracer for the clathrin-mediated endocytosis and the claudin-1 peptide. Nuclei were stained by Hoechst33342 (cyan).
Results
We synthesized two peptides, TAMRA-claudin-1
andTAMRA-claudin-5, derived from the ECL of the
corresponding claudin proteins. The fluorescence
dye TAMRA has been introducedN-terminally. The
internalization of the claudin-1–derived peptide has
been investigated on epithelial HEK-293 cells sta-
bly transfected with claudin-1-YFP, whereas the
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Figure 2. The endocytosis of the claudin-1 peptide decreases
by specific pathway inhibitors. For quantification, the number
of signal events of the claudin-1 peptide per cell was deter-
mined 35 min after addition of the peptide. All wavelengths
greater then 560 nm were collected as emission signal. For the
evaluation, all signal event intensities between 150 and 254 rel-
ative fluorescence units were calculated as number of signal
events per cell by using the Zeiss LSM Browser Software (Zeiss,
Germany). Data are represented as mean ± SEM; n = 15, ∗P <
0.05 (Mann–Whitney test, one-tailed), ns = not significant.
claudin-5 peptide has been studied on the brain en-
dothelial cell line bEnd.3, endogenously expressing
claudin-5.23 TheHEK cells were used as they exhibit
membrane localization of claudin-1 enriched in
cell–cell contacts and as the claudin-1 peptide shows
a relationship to its full-length protein. The en-
dothelial cellswere selected as they express claudin-5
in the cell contacts and as the claudin-5 peptide is re-
lated to its mother protein. To study the internaliza-
tion, we used pharmacological pathway inhibitors
to block or decrease the internalization of peptides
or applied specific tracers and vesicle markers to
determine colocalization of them and the claudin
peptide of interest.
For the TAMRA-claudin-1 peptide, Figure 1
(A–G) and Figure 2 show the internalization of
the claudin-1 peptide with and without pathway
inhibitors into transfected HEK-293 cells, the colo-
calization of the claudin-1 peptide and of a spe-
cific tracer as well as the calculated number of
signal events per cell. A clear peptide uptake could
be observed after incubation of the cells with 40M
TAMRA-claudin-1 peptide for 35 minutes (Fig. 1A,
70–80 events/cell). The uptake of the peptide by the
HEK claudin-1 cells was time-dependent. After two
hours, ∼200 and after five hours, ∼250 events/cell
were registered. Saturation was estimated between
300 and 350 events/cell after 6–24 hours.
Tofindout theuptakemechanism, different path-
way inhibitors were applied and the intracellular
amount of claudin-1 peptide was quantified by the
determination of signal events per cell (for details
see the Methods section) (Fig. 2). The lowest dif-
ference in the intracellular amount of the claudin-1
peptide compared to nontreated cells was observed
for filipin, an inhibitor of the caveolae-mediated en-
docytosis (Fig. 1B) an uptake pathway expressed in
the HEK cells used.33 Chlorpromazine, an inhibitor
of the clathrin-mediated pathway, significantly de-
creased the amount of internalized claudin-1 pep-
tide, much higher than filipin (Fig. 1C). Nearly
the same amount of internalized claudin-1 peptide
was obtained by the inhibition of macropinocyto-
sis using wortmannin (Fig. 1D) as nonreversible
inhibitor. Otherwise, the reversible macropinocyto-
sis inhibitor LY294002 showed a less efficacy than
wortmannin (Fig. 1E). However, there was still in-
ternalized claudin-1 peptide by using pathway in-
hibitors. The additive effect of chlorpromazine and
wortmannin revealed in the highest reduction of
intracellularly located claudin-1 peptide (Fig. 1F).
To confirm that the clathrin-mediated endocytosis
is involved in the peptide internalization, cells were
coincubated with the claudin-1 peptide and trans-
ferrin a tracer for this endocytosis pathway. A colo-
calization of the peptide and the tracer was observed
(Fig. 1G) with a correlation coefficient between 0.4
and 0.5. However, not all red fluorescent peptide
internalized showed overlay with the internalized
green fluorescent transferrin due to the other up-
take mechanisms found, such as macropinocytosis
and the caveolae pathway.
For the TAMRA-claudin-5 peptide, Figure 3
(A–D) and Figure 4(A–D) show the internaliza-
tion and colocalization of the claudin-5 peptide in
bEnd.3 cells and tracers as well as vesicle mark-
ers and the calculated Pearson’s correlation co-
efficients. An adequate peptide uptake could be
observed for incubation with 40 M of TAMRA-
claudin-5 for 10–30 minutes. To determine the en-
docytosis pathway several tracers have been used
and the colocalization of the corresponding tracer
and the claudin-5 peptide has been investigated.
No colocalization was determined for transferrin,
a tracer for clathrin-mediated endocytosis (Fig.
3A). On the other hand, the claudin-5 peptide
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Figure 3. The claudin-5 peptide is colocalized with tracers for the caveolae-mediated endocytosis and macropinocytosis. (A–D)
Immortalizedmouse brain endothelial cells (bEnd.3) were cotreated with the 5,6-carboxytetramethylrhodamine (TAMRA)-labeled
claudin-5 peptide (red) and the corresponding tracer (green) to determine colocalization. (A) bEnd.3 cells were treated with the
claudin-5 peptide (40 μM) for 10 and 30 minutes. The picture shows no colocalization of the claudin-5 peptide and transferrin,
a tracer for clathrin-mediated endocytosis. (B) Bodipy, a tracer for caveolae-mediated endocytosis is clearly colocalized with
the claudin-5 peptide (arrow). (C) A less efficient colocalization is given for dextran, a tracer of macropinocytosis (arrow). (D)
Evaluation of the Pearson’s correlation coefficients of the tracers and the claudin-5 peptide. Data are represented as mean ± SD,
n = 9; ∗, ∗∗, ∗∗∗, P < 0.05, 0.01, and 0.001, respectively; ns, not significant, P > 0.05 (Bonferroni test, two-way ANOVA). Scale bar,
20 μm.
clearly colocalized with the tracer bodipy, which
is internalized via caveolae-mediated endocytosis
(Fig. 3B). Ina smaller amount, a colocalizationof the
macropinocytosis tracer dextran and the claudin-5
peptide was observed (Fig. 3C). The less the con-
centration of peptide used the less was the amount
of macropinocytosis as endocytosis pathway (data
not shown). To have a closer look to the intracellu-
lar compartment of internalized claudin-5 peptide,
different specific vesicle markers have been used.
The -adaptin marker for the clathrin-mediated
endocytosis revealed no colocalization with the
claudin-5 peptide (Fig. 4B). In contrast, there was a
significant correlation between the caveolin-1-GFP
and Rab34 marker with the claudin-5 peptide,
which confirmed the endocytosis pathways deter-
mined by the tracer studies (Fig. 4A and C). In sep-
arate experiments, HEK-293 cells transfected with
claudin-5-YFP showed an internalization of the
claudin-5 peptide, whereas, the uptake by the non-
transfected cells was negligible. This is in agreement
with the imagination that the peptide inter-
nalization is related to that of the claudin
protein.
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Figure 4. The claudin-5 peptide is colocalized with vesicle markers for the caveolae-mediated endocytosis and macropinocytosis.
(A–D) Immortalizedmouse brain endothelial cells (bEnd.3) were cotreated with the 5,6-carboxytetramethylrhodamine (TAMRA)-
labeled claudin-5 peptide (red) and the corresponding vesicle marker (green) to determine colocalization. (A) The vesicle marker
caveolin-1 is colocalized with the claudin-5 peptide (arrow). (B) No colocalization is shown for α-adaptin, a tracer for the clathrin-
mediated endocytosis and the peptide. (C) A less efficient colocalization is given for the macropinocytosis vesicle marker Rab34
and the claudin-5 peptide (arrow). (D) Evaluation of the Pearson’s correlation coefficients of the vesicle markers and the claudin-5
peptide. Data are represented as mean± SD, n= 9; ∗∗, ∗∗∗P < 0.01 and 0.001, respectively; ns, not significant, P > 0.05 (Bonferroni
test, two-way ANOVA). Scale bar, 20 μm.
Discussion
Here we demonstrate that a claudin-1–derived
peptide and a claudin-5–derived peptide are in-
ternalized within the first 35 min into epithelial
and endothelial cells expressing the corresponding
claudin-subtype; that the claudin-1–derived pep-
tide is internalized by the clathrin-mediated en-
docytosis and macropinocytosis as well as to a
lower amount by the caveolae-mediated pathway;
and that the claudin-5–derived peptide is taken
up by caveolae-mediated endocytosis and in a
lesser amount by macropinocytosis, but not by
the clathrin-mediated pathway. These results are
predominantly in agreement with earlier studies
that showed the same pathways of the respective
full-length claudin proteins after extracellular stim-
uli.4–11 Only the partly caveolae-mediated pathway
for claudin-1 has not been described in earlier stud-
ies. Otherwise, here we present the internalization
of claudin peptides derived from the respective ECL
instead of the full-length claudin proteins and could
determine an internalization without any extracel-
lular stimulus. The finding that the peptides use the
same pathways as their full-length proteins supports
the assumption that the peptides are internalized
together with their proteins. This conclusion is in
agreement with the reports that the ECL, where the
peptides are derived from, mediates the cell-to-cell
association.21,29 Nevertheless, it cannot be excluded
that the uptake of the peptide segments may also
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occur independently from the uptake of the whole
protein.
The internalization and redistribution of TJ pro-
teins is an important function for the migration
of epithelial and endothelial cells as well as ves-
sels and tubuli formed by epithelia and endothe-
lia. Furthermore, for selective paracellular barrier
opening, which can enhance and/or allow drug
delivery, it is necessary to understand the exact
mechanism of TJ protein endocytosis. Moreover, to
focus on the internalization behavior of claudin
proteins, claudin-1, which can be overexpressed
in colon cancer cells30 and claudin-5, which is a
major TJ protein of the blood–brain barrier are
promising claudin targets.17,28 Thus, claudin-1 pep-
tides conjugated with cytostatic agents could be a
suitable approach to be tested as antitumor agent.
Claudin-5peptides couldhave the potential to inter-
fere with the blood–brain barrier to facilitate drug
delivery.
Recently, it has been described that the internal-
ization of TJ proteins is not only depending on an
extracellular stimulus given, but also on the cell
line and the TJ protein.4 In this study, peptides of
two different claudin subtypes are internalized in
different pathways which confirm the relevance of
claudin-subtype specificity in terms of the internal-
ization. In addition, it can be assumed that after
inhibition of a specific endocytosis pathway, sub-
stances (for example, peptides or proteins) can be
internalized via another mechanism. This could ex-
plain our results of the claudin-1 peptide by using
different inhibitors which shows still internalized
claudin-1 peptide even if an endocytosis pathway
is blocked. Otherwise, a cross-talk between differ-
ent endocytosis pathways can also not be excluded.4
Here, both claudin peptides are internalized by, at
least, twoendocytosis pathways. In recentfindingsof
the claudin-5 internalization via caveolae-mediated
endocytosis, a noncaveolae-typical early endosome
antigen 1 vesicle localization has been observed.4
The macropinocytosis is both a nonselective and an
actin-dependent internalization mechanism.7 The
uptake of large macromolecules is often described
via this endocytosis pathway in which it can take
place by an extracellular stimulation or via a consti-
tutive process.31 This could explain the observation
of this mechanism for both peptides, the claudin-
1 and the claudin-5 peptide, which has also been
described for several TJ proteins in the earlier lit-
erature.4,10,12 The subcellular localization can take
place in early endosomes, recycling endosomes, or
lysosomes.32 It has been found that, in most cases,
TJ proteins are first located into early endosomes,
followed by a recycling and a transport back to the
cell membrane.4 It seems to be that the redistribu-
tion of proteins plays a more important role than
the degradation or de novo synthesis of them.4
In summary, we show that a claudin-1 and
a claudin-5 peptide, derived from the ECL of
their corresponding claudin subtypes, are rapidly
internalized by distinct endocytosis pathways.
The claudin-1peptide is internalizedby the clathrin-
mediated endocytosis and macropinocytosis as well
as to a lower amount by the caveolae-mediated
endocytosis. The uptake of the claudin-5 pep-
tide is caveolae-mediated, whereas macropinocyto-
sis seems to be a less effective uptake mechanism.
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